EGI
PRCT icon

EAM Global Investors’s Procept Biorobotics PRCT Stock Holding History

EAM Global Investors’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-37,521
Closed -$3.02M – 134
2024
Q4 		$3.02M Buy
+37,521
New +$3.21M 0.54% 103
2022
Q4 		– Sell
-31,980
Closed -$1.33M – 223
2022
Q3 		$1.33M Sell
31,980
-11,133
-26% -$444K 0.35% 157
2022
Q2 		$1.41M Buy
+43,113
New +$1.57M 0.35% 149

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

EAM Global Investors's PRCT Position: Q1 2025 in Review

EAM Global Investors sold out of Procept Biorobotics (PRCT) in Q1 2025, closing a stake of 37,521 shares — an estimated $3.02M sold.

EAM Global Investors first reported a position in PRCT in Q2 2022 and held it in 3 quarters. The position peaked at $3.02M in Q4 2024. 279 funds tracked by Wall St. Rank hold PRCT as of Q1 2025.

  • EAM Global Investors reported no remaining Procept Biorobotics position as of Q1 2025 after selling out during the quarter.
  • EAM Global Investors sold 37,521 Procept Biorobotics shares in Q1 2025, an estimated $3.02M.
  • EAM Global Investors first reported a position in Procept Biorobotics in Q2 2022 and held it in 3 quarters.
  • EAM Global Investors's Procept Biorobotics position peaked at $3.02M in Q4 2024.
  • 279 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2025.

Based on EAM Global Investors's 13F filing for Q1 2025, filed 12 May 2025.